AWM Investment Company’s Tempest Therapeutics TPST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,021
Closed -$324K 104
2020
Q3
$324K Hold
1,021
0.05% 84
2020
Q2
$350K Sell
1,021
-2,117
-67% -$845K 0.06% 84
2020
Q1
$3.23M Hold
3,138
0.86% 39
2019
Q4
$4.12M Buy
+3,138
New +$4.42M 0.81% 46
2019
Q3
Sell
-398
Closed -$897K 97
2019
Q2
$897K Buy
398
+295
+286% +$868K 0.17% 72
2019
Q1
$300K Hold
103
0.06% 81
2018
Q4
$159K Hold
103
0.03% 83
2018
Q3
$219K Buy
+103
New +$248K 0.04% 87
2018
Q2
Sell
-51
Closed -$122K 96
2018
Q1
$122K Hold
51
0.02% 89
2017
Q4
$210K Hold
51
0.04% 91
2017
Q3
$213K Hold
51
0.04% 85
2017
Q2
$234K Hold
51
0.04% 88
2017
Q1
$280K Hold
51
0.05% 91
2016
Q4
$229K Buy
51
+34
+200% +$424K 0.04% 97
2016
Q3
$358K Hold
17
0.07% 96
2016
Q2
$260K Hold
17
0.06% 92
2016
Q1
$474K Sell
17
-23
-58% -$486K 0.1% 88
2015
Q4
$1.14M Buy
40
+1
+3% +$33K 0.22% 76
2015
Q3
$976K Buy
39
+18
+86% +$1.21M 0.19% 92
2015
Q2
$1.74M Buy
21
+18
+600% +$1.65M 0.25% 87
2015
Q1
$347K Sell
3
-22
-88% -$2.93M 0.05% 126
2014
Q4
$3.27M Buy
+25
New +$1.83M 0.45% 69

Other funds holding TPST

AWM Investment Company's TPST Position: Q4 2020 in Review

AWM Investment Company sold out of Tempest Therapeutics (TPST) in Q4 2020, closing a stake of 1,021 shares — an estimated $324K sold.

AWM Investment Company first reported a position in TPST in Q4 2014 and held it in 22 quarters. The position peaked at $4.12M in Q4 2019. 37 funds tracked by Wall St. Rank hold TPST as of Q4 2020.

  • AWM Investment Company reported no remaining Tempest Therapeutics position as of Q4 2020 after selling out during the quarter.
  • AWM Investment Company sold 1,021 Tempest Therapeutics shares in Q4 2020, an estimated $324K.
  • AWM Investment Company first reported a position in Tempest Therapeutics in Q4 2014 and held it in 22 quarters.
  • AWM Investment Company's Tempest Therapeutics position peaked at $4.12M in Q4 2019.
  • 37 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q4 2020.

Based on AWM Investment Company's 13F filing for Q4 2020, filed 12 Feb 2021.